ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735037; 2) Community: the network communities that were significantly associated with the response to NSC 735037; 3) Molecule: the relationships between components within communities and NSC 735037; 4) MDR: the compounds that were significantly associated with the NSC 735037.

NSC Compound Enrichment Correlation
NSC 154948 M-AMSA 0.0164116791870034 0.73877427
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0164116791870034 0.31749499
NSC 244404 Null 0.0164116791870034 0.11634968
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0164116791870034 0.21510694
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0164116791870034 0.55654031
NSC 300289 Pinafide 0.0164116791870034 0.73386779
NSC 303812 Aphidicoline glycinate 0.0164116791870034 0.79718996
NSC 328410 Camptothecin Derivative 0.0164116791870034 0.69041775
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0164116791870034 0.54418636
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0164116791870034 0.47381762
Total:91  Current:32    [First] [Prev] [Next] [Last]